SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 8:45 pm Purchase | 2025-02-07 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 3,022,612 5.500% | 917,348 (+43.57%) | Filing |
| 2025-02-11 8:20 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,105,264 3.800% | -3,358,377 (-61.47%) | Filing |
| 2024-02-13 12:13 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 5,463,641 9.990% | 491,981 (+9.90%) | Filing |
| 2023-02-13 10:11 am Purchase | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 4,971,660 9.990% | 2,332,885 (+88.41%) | Filing |
| 2022-02-11 5:25 pm Purchase | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,638,775 7.200% | 586,417 (+28.57%) | Filing |
| 2021-08-20 4:36 pm Purchase | 2021-08-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,052,358 5.600% | 2,052,358 (New Position) | Filing |